WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025. The Chinese contract research, development, and ...

Wuxi, Jiangsu province, is celebrating its International Month and International Cherry Blossom Week, highlighting the city's ...

Wuxi, Jiangsu province, is celebrating its International Month and International Cherry Blossom Week, highlighting the city's renowned cherry blossoms and its efforts to enhance international ...

Photo by Allie Kent, courtesy of the Springer Opera House. Whatever label a critic places on Jesus Christ Superstar, at the Springer Opera House, it is a spirited evening. Director and ...

CORRECTION: WuXi Biologics has disputed a claim by WBJ construction has stopped at its Worcester facility. An earlier version of this article incorrectly conflated details involving WuXi Biologics ...

Central Pest's Hungarian State Opera House has been an institution in Budapest since its opening in 1884. Featuring a neo-Renaissance style, the opera house holds more than 1,200 seats and has a ...

U.S. News Insider Tip: If your Munich visit coincides with the opera’s annual summer festival and you’d like to attend a free live broadcast from the National Theatre/open-air concert at Max ...

To address the challenges in producing these biomolecules, WuXi Biologics has introduced the EffiX™ platform, which enables the development and manufacturing of microbial-derived biologics with ...

Most would find it surprising that The Metropolitan Opera Management sued to have their own opera house razed, but that is exactly what happened in the mid-1960s. The Metropolitan Opera ...

Talents People are WuXi Biologics' greatest assets. As of December 31, 2024, the Group's total employee count reached 12,575, including 4,383 scientists, with a key talent retention rate of 95.8%. The ...

WuXi AppTec expects sales to grow 10% to 15% in 2025 as the fate of the BIOSECURE Act remains uncertain. And more. 1. AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer ...

Dr. Jimmy Li, CEO of WuXi XDC, stated, "The year 2024 has been another year ... We have made significant strides in expanding our global presence, enhancing our in-house technology capabilities, and ...